Amelioration of Cognitive, Motor and Endogenous Defense Functions with Silymarin, Piracetam and Protocatechuic Acid in the Cerebral Global Ischemic Rat Model
Overview
Biology
Physiology
Affiliations
Aims: The neuroprotective activities of silymarin, piracetam and protocatechuic acid ethyl ester (PCA) on cerebral global ischemic/reperfusion were evaluated in a rat model.
Main Methods: A midline ventral incision was made in the throat region. The right and left common carotid arteries were located and a bilateral common carotid artery occlusion (BCCAO) was performed for 30min using atraumatic clamps followed by a 24h period of reperfusion. Neurological/behavioral functions (cognitive and motor), endogenous defense systems (lipid peroxidation, glutathione, catalase, and superoxide dismutase), reduced water content and infarct size and histopathological alterations were then studied.
Key Findings: Silymarin and PCA treatments significantly improved cognitive, motor and endogenous defense functions, histopathological alterations, and, reduced both water content and infarct size compared to the vehicle-treated ischemic control group. Piracetam treatment improved neurological and histopathological alterations, reduced water content and infarct size, but failed to restore/prevent the impaired endogenous defense functions significantly.
Significance: Silymarin showed better neuroprotection than piracetam and PCA in experimentally induced global ischemic/reperfusion and was able to facilitate mnemonic performance.
Rodriguez-Cortes Y, Ramirez-Carreto R, Rodriguez-Barrena J, Salazar-Castro M, Chavarria A Front Aging Neurosci. 2024; 16:1484946.
PMID: 39624169 PMC: 11609184. DOI: 10.3389/fnagi.2024.1484946.
Research Progress on the Mechanisms of Protocatechuic Acid in the Treatment of Cognitive Impairment.
Liang S, Zhao Z, Liu L, Zhang Y, Liu X Molecules. 2024; 29(19).
PMID: 39407652 PMC: 11478363. DOI: 10.3390/molecules29194724.
Liu J, Yang N, Wang X, Wang W Exp Brain Res. 2024; 242(8):1841-1850.
PMID: 38842755 DOI: 10.1007/s00221-024-06868-x.
Saad K, Lopes Salles E, Naeini S, Baban B, Abdelmageed M, Abdelaziz R Pharmacol Rep. 2024; 76(1):98-111.
PMID: 38214881 DOI: 10.1007/s43440-023-00565-2.
Karim A, Anwar F, Saleem U, Fatima S, Ismail T, Obaidullah A Metab Brain Dis. 2023; 38(7):2255-2267.
PMID: 37458892 DOI: 10.1007/s11011-023-01258-8.